The Western immunoblot for Lyme disease: Determination of sensitivity, specificity, and interpretive criteria with use of commercially available performance panels

Clinical Infectious Diseases

Volumn 25, Issue 1 SUPPL., 1997, Pages

  Tilton, Richard C ^a   Sand, Mary N ^b   Manak, Mark ^b  

^a BBI Clinical Laboratories   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

BORRELIA BURGDORFERI; CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; INTERMETHOD COMPARISON; LYME DISEASE; PRIORITY JOURNAL; SERODIAGNOSIS;

EID: 0030844535     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/516173     Document Type: Conference Paper

References (5)

1. Bacon LL, Case KL, Callister SM, et al. Performance of 45 laboratories participating in a proficiency testing program for Lyme disease serology. JAMA 1992;268:891-5.
2. Magnarelli LA, Meegan JM, Anderson JF, et al. Comparison of an indirect fluorescent antibody test with an enzyme-linked immunosorbent assay for serological studies of Lyme disease. J Clin Microbiol 1984;20: 181-4.
3. Fister RD, Weymouth LA, Mardi JC, et al. Comparative evaluation of three products for the detection of Borrelia burgdorferi antibody in human serum. J Clin Microbiol 1989;27:2834-7.
4. Centers for Disease Control and Prevention, Association of State and Territorial Public Health Laboratory Directors. Proceedings of the Second National Conference on Serologic Diagnosis of Lyme Disease (Dearborn, MI). Washington, DC: Association of State and Territorial Public Health Laboratory Directors. 1994.
5. Schmidt BL. Laboratory diagnosis of human Borrelia burgdorferi infections. Clin Microbiol Rev 1997;10:185-201.